BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12889074)

  • 1. The story of penicillamine: a difficult birth.
    Walshe JM
    Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
    [No Abstract]   [Full Text] [Related]  

  • 2. 50 Years Ago in TheJournal ofPediatrics: Hepatolenticular Degeneration: The Comparative Effectiveness of D-Penicillamine, Potassium Sulfide, and Diethyldithiocarbamate as Decoppering Agents.
    Hafberg ET
    J Pediatr; 2016 Jun; 173():55. PubMed ID: 27234281
    [No Abstract]   [Full Text] [Related]  

  • 3. The discovery of the therapeutic use of D-penicillamine.
    Walshe JM
    J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A copper for your thoughts.
    Coates RA
    J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
    [No Abstract]   [Full Text] [Related]  

  • 5. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
    Schilsky M
    Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
    [No Abstract]   [Full Text] [Related]  

  • 6. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
    Smithgall JM
    J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
    Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
    [No Abstract]   [Full Text] [Related]  

  • 8. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
    Delangle P; Mintz E
    Dalton Trans; 2012 Jun; 41(21):6359-70. PubMed ID: 22327203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 10. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
    Hoogenraad TU
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1386-7. PubMed ID: 12892020
    [No Abstract]   [Full Text] [Related]  

  • 11. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 12. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Wilson's disease. Hepatic manifestations].
    Oliveira e Silva A; Roldan Molina LF; dos Santos TE; Santo GC; Gama-Rodrigues JJ; D'Albuquerque LA
    Arq Gastroenterol; 1989; 26(3):47-9. PubMed ID: 2697201
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of a Liver Biopsy in the Management of Wilson Disease.
    Oe S; Honma Y; Yabuki K; Morino K; Kumamoto K; Hayashi T; Kusanaga M; Ogino N; Minami S; Shibata M; Abe S; Harada M
    Intern Med; 2020 Jan; 59(1):77-81. PubMed ID: 31511488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 18. Brief observations on the management of Wilson's disease.
    Walshe JM
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):1-3. PubMed ID: 122651
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotypies in Wilson's disease.
    Yorio AA; Mesri JC; Pagano MA; Lera G
    Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
    [No Abstract]   [Full Text] [Related]  

  • 20. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.